Want to join the conversation?
$MYL's largest contributing segment Generics third party net sales rose 22% to $2.22Bil vs. 4Q14, helped by higher sales in North America, Europe and Rest of World. Specialty segment reported third party net sales rose 5% vs. 4Q14 helped by higher net sales of the EpiPen Auto-Injector due to higher volumes.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.